Triptodur FDA Approval History
FDA Approved: Yes (First approved June 29, 2017)
Brand name: Triptodur
Generic name: triptorelin
Dosage form: Injection
Company: Azurity Pharmaceuticals, Inc.
Treatment for: Precocious Puberty
Triptodur (triptorelin) is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients with central precocious puberty.
Development timeline for Triptodur
| Date | Article |
|---|---|
| Jun 30, 2017 | Approval Arbor Pharmaceuticals, LLC Announces FDA Approval for Triptodur (triptorelin) |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.